Biomaterial Database

[Treatment of intestinal helminthiases using a new drug combination: pyrantel pamoate and thiabendazole]. 1976

D Huggins

UI	MeSH Term	Description	Entries
D008297	Male		Males
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D011715	Pyrantel	A depolarizing neuromuscular-blocking agent, that causes persistent nicotinic activation resulting in spastic paralysis of susceptible nematodes. It is a drug of second-choice after benzimidazoles for treatment of ascariasis, hookworm, and pinworm infections, being effective after a single dose. (From Smith and Reynard, Textbook of Pharmacology, 1992, p920)
D011716	Pyrantel Pamoate	Broad spectrum antinematodal anthelmintic used also in veterinary medicine.	Pyrantel Embonate,Antiminth,Combantrin,Embovin,Embonate, Pyrantel,Pamoate, Pyrantel
D002648	Child	A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.	Children
D002675	Child, Preschool	A child between the ages of 2 and 5.	Children, Preschool,Preschool Child,Preschool Children
D004338	Drug Combinations	Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture.	Drug Combination,Combination, Drug,Combinations, Drug
D004341	Drug Evaluation	Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals.	Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260	Female		Females
D006373	Helminthiasis	Infestation with parasitic worms of the helminth class.	Nematomorpha Infections,Infections, Nematomorpha,Helminthiases,Infection, Nematomorpha,Nematomorpha Infection